Back to results
US 9,775,896 B2Granted
Tissue targeted antigenic activation of the immune response to treat cancers
AssigneeQu Biologics Inc.
InventorHarold David Gunn
Life of this patent
Estimating the term…
Abstract
The invention provides in part methods of treating cancers of a specific organ or tissue by administering a composition that is antigenically specific for one or more microbes that are pathogenic in the specific organ or tissue in which the cancer is situated.
Claims10
A method for treating a human patient for a melanoma situated in the skin or skin tissue, the method comprising:
- administering to the patient at a site different from the melanoma a medicament comprising an effective amount of whole cells of attenuated or killed Staphylococcus aureus (S. aureus) as the sole active agent effective for treating the melanoma.
A method for treating a human patient for a melanoma situated in the skin or skin tissue, the method comprising:
- administering to the patient at a site different from the melanoma a medicament comprising an effective amount of whole cells of attenuated or killed Staphylococcus aureus (S. aureus), wherein microbial antigenic determinants of the whole cells are the sole antigens for treating the melanoma.
Dependencies are inferred from the claim text.